7 November 2013
Immunocore today announced the achievement of its first milestone in its major research and licensing agreement with GlaxoSmithKline (GSK) for multiple novel targets. The achievement comes less than four months after the companies signed their agreement.
Please click on the link below to download the full Press Release:
Immunocore achieves research milestone in GlaxoSmithKline collaboration
